Know What's Happening in Science

Today's Science Pulse

UK-led study reveals hidden massive star clusters deep inside nearby galaxies

Astronomers using the VLA and ALMA uncovered previously unseen giant star clusters, described as "ring factories," embedded within nearby galaxies. A complementary analysis of roughly 18,000 star‑forming regions showed that the energetic activity of young stars plays a decisive role in shaping galaxy evolution.

All Five DNA/RNA Nucleobases Detected in Pristine Ryugu Samples
NewsMar 29, 2026

All Five DNA/RNA Nucleobases Detected in Pristine Ryugu Samples

Scientists analyzing pristine material from asteroid Ryugu have identified adenine, guanine, cytosine, thymine and uracil—the complete set of canonical nucleobases used in DNA and RNA. The findings, based on 5.4 g of contamination‑controlled samples, provide direct evidence that these biomolecules can...

By Pulse
Habit‑Based Self‑Control Research Shows Effortless Discipline Can Be Learned
NewsMar 29, 2026

Habit‑Based Self‑Control Research Shows Effortless Discipline Can Be Learned

Psychologists Denise de Ridder and Johanna Peetz highlighted recent research indicating that self‑control can be built through small, repeatable habits rather than taxing willpower. Experiments show participants who kept modest daily goals for three months reported stronger habits and less...

By Pulse
Ex‑NFL Pro Bowler Julius Thomas Links Mindset Training to Longevity
NewsMar 29, 2026

Ex‑NFL Pro Bowler Julius Thomas Links Mindset Training to Longevity

In a recent interview, former two‑time NFL Pro Bowler Julius Thomas, Psy.D., outlined a new framework that ties mental‑training techniques to longer, healthier lives. He argues that chronic stress at the cellular level and low‑grade inflammation are the hidden culprits...

By Pulse
Biohackers World Sets 2026 Los Angeles Longevity Conference for 1,500 Attendees
NewsMar 29, 2026

Biohackers World Sets 2026 Los Angeles Longevity Conference for 1,500 Attendees

Biohackers World announced a two‑day conference in Los Angeles on March 28‑29, 2026, slated to draw about 1,500 researchers, founders and enthusiasts. The event will shift the biohacking conversation toward everyday habits, supportive technology and environmental design. Organizers say the...

By Pulse
Eli Lilly’s Retatrutide Shows Strong Weight‑Loss Results, Poised to Disrupt Obesity Market
NewsMar 29, 2026

Eli Lilly’s Retatrutide Shows Strong Weight‑Loss Results, Poised to Disrupt Obesity Market

Eli Lilly’s experimental injectable retatrutide has reported substantial weight‑loss outcomes in a 2023 trial, positioning it as a potential challenger to existing GLP‑1 drugs. The triple‑agonist targets three metabolic receptors, and large Phase 3 studies are now under way, drawing attention...

By Pulse
NASA Accelerates $20 B Moon Base Push, Redefining U.S. Space Leadership
NewsMar 29, 2026

NASA Accelerates $20 B Moon Base Push, Redefining U.S. Space Leadership

NASA announced a $20 billion acceleration of a permanent lunar base, abandoning the Gateway orbital station in favor of surface infrastructure. The move, framed as a leadership response to China’s fast‑moving lunar program, aims for a foothold on the Moon within...

By Pulse
TotalEnergies Cuts Methane Emissions 65% Ahead of 2025 Goal
NewsMar 29, 2026

TotalEnergies Cuts Methane Emissions 65% Ahead of 2025 Goal

TotalEnergies announced a 65% reduction in operated methane emissions since 2020, surpassing its 60% cut target for 2025. The progress, detailed in its 2026 Sustainability Report, comes alongside a 38% fall in overall greenhouse‑gas output and a rapid expansion of...

By Pulse
Chinese AI Firms Turn Niche Data Play Into Profit, XtalPi Posts $19.5M Gain
NewsMar 29, 2026

Chinese AI Firms Turn Niche Data Play Into Profit, XtalPi Posts $19.5M Gain

Chinese AI companies XtalPi and Blacklake have moved from loss‑making research to sustainable profitability by targeting specialized data‑driven markets. XtalPi reported a 134.6 million‑yuan ($19.5 million) profit in 2025, while Blacklake achieved its first profit in late 2024, underscoring a shift in...

By Pulse
Porous Carbon 'Viciazites' Enable Low‑heat CO₂ Capture, Cutting Costs
NewsMar 29, 2026

Porous Carbon 'Viciazites' Enable Low‑heat CO₂ Capture, Cutting Costs

Researchers at Chiba University have created a redesigned porous carbon nanomaterial called viciazites that captures CO₂ and releases it at temperatures under 60 °C, dramatically lowering energy input. The breakthrough hinges on precisely positioned nitrogen groups, achieving up to 82% selectivity...

By Pulse
AST SpaceMobile’s Bluebird 6 Antenna Spurs 196% Stock Surge Amid Funding Crunch
NewsMar 29, 2026

AST SpaceMobile’s Bluebird 6 Antenna Spurs 196% Stock Surge Amid Funding Crunch

AST SpaceMobile’s launch of Bluebird 6, the largest LEO communications‑array antenna, has propelled its shares up 196% over the past year. The rally comes as the company raises $3.9 bn in new financing while posting a $340 m net loss, highlighting both investor...

By Pulse
Northwestern Researchers Unveil 'Metamachines'—Modular Robots That Survive Limb Loss
NewsMar 29, 2026

Northwestern Researchers Unveil 'Metamachines'—Modular Robots That Survive Limb Loss

Researchers at Northwestern University introduced "metamachines," modular robots that keep crawling even after a limb is severed. The breakthrough showcases a new class of shape‑shifting machines that could redefine robotics in unstructured environments.

By Pulse
Nektar's Rezpegaldesleukin Shows Strong Gains in Atopic Dermatitis and Alopecia Areata at AAD 2026
NewsMar 29, 2026

Nektar's Rezpegaldesleukin Shows Strong Gains in Atopic Dermatitis and Alopecia Areata at AAD 2026

Nektar Therapeutics presented Phase 2b data for its regulatory T‑cell agonist rezpegaldesleukin at the 2026 American Academy of Dermatology meeting, showing statistically significant EASI improvements in 393 atopic dermatitis patients and a 28.2% mean SALT reduction in severe alopecia areata....

By Pulse
Hib Vaccine Shields Against Meningitis, Pneumonia, Epiglottitis
SocialMar 29, 2026

Hib Vaccine Shields Against Meningitis, Pneumonia, Epiglottitis

The Hib vaccine protects against Haemophilus influenzae type b (Hib) bacteria, which can cause severe illnesses like meningitis, pneumonia, and epiglottitis. Th

By Dr. Leslie Treece, MD
13-Year Study Becomes One of Cell’s Longest Papers
SocialMar 29, 2026

13-Year Study Becomes One of Cell’s Longest Papers

This paper took us 13 years and is one of the longest papers ever in Cell. Check it out & judge for yourself https://t.co/Ra0CX1i5zt https://t.co/LbGXx2u4cq

By David Sinclair, PhD
CERN Burns Ultra‑Small AI Models Into Silicon to Filter LHC Data in Real Time
NewsMar 29, 2026

CERN Burns Ultra‑Small AI Models Into Silicon to Filter LHC Data in Real Time

CERN has integrated ultra‑compact AI models directly into silicon chips, enabling the Level‑1 Trigger to discard 99.98% of LHC collision data in under 50 nanoseconds. The move replaces conventional GPUs with custom FPGA/ASIC implementations, addressing a data stream of up...

By Pulse
The Economics of Openness: Funding Earth Observation as a Public Good
BlogMar 28, 2026

The Economics of Openness: Funding Earth Observation as a Public Good

Earth observation (EO) data are now widely accessible through open archives, cloud platforms and shared tools, yet true public use remains limited. The article argues that openness is more than data availability; it requires institutional capacity, sustained funding, and clear...

By GovLab — Digest —
Very Low LDL Levels Best in Secondary Prevention: Ez-PAVE
NewsMar 28, 2026

Very Low LDL Levels Best in Secondary Prevention: Ez-PAVE

New randomized data from the Ez‑PAVE trial in South Korea show that lowering LDL cholesterol to below 55 mg/dL in patients with established atherosclerotic cardiovascular disease reduces major cardiovascular events by 33% compared with a target of less than 70 mg/dL. The...

By TCTMD
Supercomputer Maps Spliceosome Dynamics, Advancing Gene‑Splicing Drug Design
SocialMar 28, 2026

Supercomputer Maps Spliceosome Dynamics, Advancing Gene‑Splicing Drug Design

Supercomputer simulations of a two-million-atom human cell model have mapped the dynamic motions of the spliceosome, offering detailed insights into gene splicing mechanisms and informing future drug development. computationalbiology

By Phys.org Threads
UCL and RAD Publish Study on Quiet Electric Marine Technology
NewsMar 28, 2026

UCL and RAD Publish Study on Quiet Electric Marine Technology

University College London and electric marine propulsion firm RAD have released a peer‑reviewed study demonstrating that RAD’s 40 kW electric outboard reduces underwater noise by up to 43 dB compared with a comparable internal combustion engine. Tests on the River Hamble and...

By The Maritime Executive
#AAD26: Biogen Declares Phase 2 Lupus Success for Anti-BDCA2 Antibody
NewsMar 28, 2026

#AAD26: Biogen Declares Phase 2 Lupus Success for Anti-BDCA2 Antibody

Biogen announced positive Phase 2 results for litifilimab, its anti‑BDCA2 antibody targeting systemic lupus erythematosus. After 24 weeks, 14.7% of patients achieved complete clearance of skin lesions, meeting the trial’s primary endpoint. The data suggest the drug could become a...

By Endpoints News
How Living at High Altitudes Can Protect Against Diabetes
NewsMar 28, 2026

How Living at High Altitudes Can Protect Against Diabetes

A new study from the Gladstone Institutes explains why living at high altitude reduces diabetes risk. Researchers discovered that under hypoxic conditions red blood cells dramatically increase glucose uptake, using it to produce 2,3‑DPG and release more oxygen. The team...

By New Atlas – Architecture
KARDINAL: Monthly Tonlamarsen May Not Enhance BP Lowering in Resistant Hypertension
NewsMar 28, 2026

KARDINAL: Monthly Tonlamarsen May Not Enhance BP Lowering in Resistant Hypertension

The phase II KARDINAL trial evaluated monthly versus single‑dose tonlamarsen, an angiotensinogen‑targeted nucleic‑acid therapy, in patients with resistant hypertension on multiple drugs. While monthly injections achieved a 67% reduction in plasma AGT compared with 23% after a single dose, both regimens...

By TCTMD
Dogs Coexisted with Humans 14,000 Years Pre‑agriculture
SocialMar 28, 2026

Dogs Coexisted with Humans 14,000 Years Pre‑agriculture

Ancient DNA analysis shows that domesticated dogs lived alongside humans in Western Eurasia over 14,000 years ago, sharing diets and forming close bonds long before the advent of agriculture. archaeology

By Phys.org Threads
Quantum Simulators Harbour Hidden Bugs, New Research Confirms
BlogMar 28, 2026

Quantum Simulators Harbour Hidden Bugs, New Research Confirms

An empirical study by LSU examined 394 confirmed bugs across twelve open‑source quantum simulators, revealing a far higher defect rate than previously assumed. The research shows that 60 % of failures stem from classical infrastructure such as memory management, while only...

By Quantum Zeitgeist
Starfish Space Finds a New Partner for Docking Demonstration Mission
NewsMar 28, 2026

Starfish Space Finds a New Partner for Docking Demonstration Mission

Starfish Space announced that its Otter Pup 2 docking demonstration will target a new, still‑undisclosed partner after D‑Orbit withdrew in late 2025. The spacecraft, launched in June 2025, uses an electrostatic capture system to attach to flat surfaces on satellites lacking a...

By SpaceNews
Astronomers Spot Ultra‑Metal‑Poor Star in Dwarf Galaxy, a Fossil of the Early Universe
NewsMar 28, 2026

Astronomers Spot Ultra‑Metal‑Poor Star in Dwarf Galaxy, a Fossil of the Early Universe

An international team of astronomers has identified an ultra‑metal‑poor star in a nearby dwarf galaxy, providing a direct window into the chemical makeup of the early universe. The star’s iron abundance is less than one ten‑thousandth that of the Sun,...

By Pulse
Chinese Team Demonstrates First Silicon Quantum Chip with Full Logical Operations
NewsMar 28, 2026

Chinese Team Demonstrates First Silicon Quantum Chip with Full Logical Operations

Researchers at Shenzhen International Quantum Academy have built a silicon quantum processor that executes a complete set of error‑detecting logical operations using four physical qubits. The chip ran a Variational Quantum Eigensolver algorithm on a water molecule, delivering results within...

By Pulse
Pink Noise Worsens Sleep Quality when Used to Block Out Traffic and City Noise
NewsMar 28, 2026

Pink Noise Worsens Sleep Quality when Used to Block Out Traffic and City Noise

New research published in Sleep shows that pink noise, often marketed as a sleep aid, actually reduces REM sleep by about 19 minutes, worsening overall sleep quality. In a controlled seven‑night lab study with 25 healthy adults, intermittent traffic noise...

By PsyPost
Merck Buys TERN, CORT Gets FDA Cancer Nod as Trials Split, Anavex Pulls EU Filing
NewsMar 28, 2026

Merck Buys TERN, CORT Gets FDA Cancer Nod as Trials Split, Anavex Pulls EU Filing

Merck announced a cash deal to acquire TERN, while CORT secured FDA clearance for its cancer therapy. In parallel, INSM reported positive trial data, VALN fell short of expectations, and Anavex withdrew its EU filing for an Alzheimer’s candidate.

By Pulse
Thousands of Americans Treated With Psilocybin in 2025
NewsMar 28, 2026

Thousands of Americans Treated With Psilocybin in 2025

Psilocybin therapy is rapidly expanding across U.S. states, with Oregon reporting 5,935 patients in 2025 and Colorado opening its first regulated healing center. New Mexico is developing its own medical program while the federal government maintains prohibition. Scientific evidence shows...

By Slashdot
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care
NewsMar 28, 2026

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care

Takeda announced that its oral TYK2 inhibitor zasocitinib delivered rapid and durable skin clearance in two global Phase 3 LATITUDE trials involving 693 and 1,108 moderate‑to‑severe plaque psoriasis patients. The drug met both co‑primary endpoints—sPGA 0/1 and PASI 75 at week 16—showing statistically significant...

By Financial Post — Deals
Can You Change an 88-Year-Old Brain?
NewsMar 28, 2026

Can You Change an 88-Year-Old Brain?

An 88‑year‑old civil‑rights veteran used an AI‑powered dyslexia program and saw his reading accuracy jump from 50 % to 80 % in phonemic awareness. Clinical evidence shows that neuroplasticity remains viable in seniors, allowing language‑based cognitive training to improve reading and memory...

By Psychology Today (site-wide)
New England Journal of Medicine Publishes Positive Phase 3 VALOR Trial Results of Brepocitinib in Dermatomyositis
NewsMar 28, 2026

New England Journal of Medicine Publishes Positive Phase 3 VALOR Trial Results of Brepocitinib in Dermatomyositis

Priovant Therapeutics announced that its TYK2/JAK1 inhibitor brepocitinib met the primary endpoint in the Phase 3 VALOR trial for dermatomyositis, showing a 15.3‑point improvement in Total Improvement Score at week 52 versus placebo. The 30 mg dose also delivered significant steroid‑sparing effects, with...

By Business Insider – Markets Insider
Can We Measure Climate Change's Impact on Mental Health?
NewsMar 28, 2026

Can We Measure Climate Change's Impact on Mental Health?

Climate change is increasingly linked to mental‑health outcomes, yet no global indicator reliably captures this relationship. Researchers highlight the difficulty of attributing specific weather events—such as stronger hurricanes or unprecedented heat‑humidity—to depression, anxiety, or suicide. Data gaps, inconsistent diagnoses, and...

By Psychology Today (site-wide)
[Story] Human Alignment Isn't Enough
BlogMar 28, 2026

[Story] Human Alignment Isn't Enough

A speculative story describes a Martian organism discovered in cave expeditions that rapidly self‑assembles and emits molecules enabling synthetic computation, boosting human cognition and cooperation by about 20%. The material’s side effects led to a 2‑percentage‑point solar‑cell efficiency breakthrough and...

By LessWrong
Combining Modest Therapies Unlocks Big Benefits, Reduces Waste
SocialMar 28, 2026

Combining Modest Therapies Unlocks Big Benefits, Reduces Waste

Adam, I used to think this way. Then gene therapy & IO worked. IL2 has consumed a lot of hope; but new variations make it hard to quit. Abeta worked. And synergy: combine modest drugs, unlock big benefits. Invest or...

By Peter Kolchinsky
Procrastination Driven by Threat, Freeze, and Brain Imbalance
SocialMar 28, 2026

Procrastination Driven by Threat, Freeze, and Brain Imbalance

The Neuroscience Of Procrastination: 1. Perceived Threat (Amygdala Activation). 2. The "Freeze" Response. 3. Prefrontal Cortex Underactivity. 4. The Cycle Of Relief.

By Hasti Afkhami, LMFT
Co-Occurring Depression and Cannabis Use Linked to Less Efficient Brain Networks
NewsMar 28, 2026

Co-Occurring Depression and Cannabis Use Linked to Less Efficient Brain Networks

A new study published in *Drug and Alcohol Dependence* examined 395 adults and found that regular cannabis use boosts global brain efficiency, but co‑occurring depression symptoms blunt this effect, leading to less integrated neural networks. Using resting‑state fMRI and graph‑theory...

By PsyPost
New Atlas Maps All Human E3 Ligases, Unifying Research
SocialMar 28, 2026

New Atlas Maps All Human E3 Ligases, Unifying Research

A comprehensive atlas now defines all human E3 ligases, resolving decades of inconsistencies and providing a unified framework to advance research and therapeutic development for diseases linked to these essential enzymes. biotechnology

By Phys.org Threads
Brain Mysteries Remain Unsolved After Two Decades
SocialMar 28, 2026

Brain Mysteries Remain Unsolved After Two Decades

"Ten Unsolved Mysteries of the Brain" in Discover Magazine. I wrote this article 19 years ago. Amazingly, these are still the mysteries we face. https://t.co/SIfEB8VkUv

By David Eagleman
Researchers Prefer Automating Writing, Not Idea Generation
SocialMar 28, 2026

Researchers Prefer Automating Writing, Not Idea Generation

The researchers I know are far more likely to love this than hate it. You really think people enjoy the process of writing papers vs the actual hypothesis generation and designing & steering the research? Automate everything that can...

By Ramez Naam
Psilocybin Emerges as Promising Longevity Therapy
SocialMar 28, 2026

Psilocybin Emerges as Promising Longevity Therapy

When I started Don't Die in 2021, we evaluated all the scientific evidence for the most powerful anti-aging therapies. Psychedelics were no where to be found. A wild turn of events that they're now front and center for us....

By Bryan Johnson
Microbial Phenolics Mediate Oats' Cholesterol‑lowering Power
SocialMar 28, 2026

Microbial Phenolics Mediate Oats' Cholesterol‑lowering Power

Cholesterol-lowering effects of oats induced by microbially produced phenolic metabolites in metabolic syndrome: a randomized controlled trial "Here we show that microbial phenolic metabolites are driving factors for the cholesterol-lowering effect of oats.." https://t.co/Y6fmNYStmZ

By David Barzilai, MD PhD
PCSK9 Inhibitor Cuts Cardiovascular Events in Diabetics
SocialMar 28, 2026

PCSK9 Inhibitor Cuts Cardiovascular Events in Diabetics

In a randomized trial of a PCSK9 inhibitor [for LDL cholesterol lowering] vs placebo for patients with diabetes and no known heart disease, there was significant reduction of major cardiovascular events including deaths #ACC26 @JAMA_current https://t.co/mzuI79c4IN https://t.co/16Cpxf7IBx

By Eric Topol
Neural Network Denoises Ultrasound for Foggy Aerial Navigation
SocialMar 28, 2026

Neural Network Denoises Ultrasound for Foggy Aerial Navigation

A new Science #Robotics study highlights Saranga, a deep neural network that can denoise ultrasound echolocation signals to improve aerial navigation even in dense fog, snow, or darkness. @nitinjsanket https://t.co/utyw7UGfJ9 https://t.co/ElinoMN830

By Science Robotics
Intensive LDL < 55 Mg/dL Cuts Cardiovascular Events
SocialMar 28, 2026

Intensive LDL < 55 Mg/dL Cuts Cardiovascular Events

Validation of aggressive LDL lowering to reduce major adverse cardiovascular events, a randomized trial targeting LDL < 55 mg/dl. In participants with atherosclerotic cardiovascular disease (secondary prevention) @NEJM #ACC26 https://t.co/oLnkqhawOd

By Eric Topol
NASA Announces $20 B Moon Base and Nuclear Mars Ship
SocialMar 28, 2026

NASA Announces $20 B Moon Base and Nuclear Mars Ship

Now @NASA Unveils Its $20 Billion Moon Base Plan—and a Nuclear Spacecraft for Mars by @EddyTheGent https://t.co/2xGqkZeZyd https://t.co/N24jKsM0AN

By Brian Ahier
AI Meets Scalable Single-Cell Data, Transforming Medicine
SocialMar 28, 2026

AI Meets Scalable Single-Cell Data, Transforming Medicine

AI needs data. And biology is finally generating it at scale. I spoke with @10xGenomics CEO Serge Saxonov about the single-cell and spatial biology revolution — and why the convergence of AI + biological measurement could transform medicine. Read the full profile...

By John Cumbers
Evolution Enables Shape‑Shifting Within a Single Lifetime
SocialMar 28, 2026

Evolution Enables Shape‑Shifting Within a Single Lifetime

Just so amazing evolution found a way to change shape in a single lifespan. Some of the cell types run a few laps around the cocoon too.

By Sebastian Cocioba